EUVIMEDEUVIMED entdecken
Crossref

Reversal of Cisplatin Resistance in Ovarian Cancer by the Multitargeted Nanodrug Delivery System Tf-Mn-MOF@Nira@CDDP

Yuan Liu, Yiru Wang, Xue Guan, Qiong Wu, Mengjun Zhang, Ping Cui, Can Wang, Xiuwei Chen, Xianwei Meng iD, Tengchuang Ma

ACS Applied Materials & Interfaces · 2023

DOI: 10.1021/acsami.3c05374 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2023. Verfasst von Yuan Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Harbin Medical University Cancer Hospital, Nangang District, Harbin, Heilongjiang Province 150086, P.R. China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Ovarian Neoplasms, Nanoparticles. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Harbin Medical University Cancer Hospital, National Natural Science Foundation of China, Heilongjiang Provincial Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsOvarian NeoplasmsNanoparticlesHumansFemaleAnimalsMiceCisplatinTransferrinCell Line, TumorDrug Resistance, NeoplasmIndazolesPiperidines

Stichwörter der Autor:innen

cisplatin resistanceglutathionemetal−organic frameworkniraparibovarian cancer

Substanzen

CisplatinAntineoplastic AgentsTransferrinniraparibIndazolesPiperidines

Autor:innen und Institutionen

  • Department of Gynecology, Harbin Medical University Cancer Hospital, Nangang District, Harbin, Heilongjiang Province 150086, P.R. China.
  • Animal Laboratory Center, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province 150086, P.R. China.
  • Laboratory of Controllable Preparation and Application of Nanomaterials, Key Laboratory of Cryogenics, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, No. 29 East Road Zhongguancun, Beijing 10…
  • Department of Nuclear Medicine, Harbin Medical University Cancer Hospital, Nangang District, Harbin, Heilongjiang Province 150086, P.R. China.

ORCID-Profile: Xianwei Meng

Förderung

  • Harbin Medical University Cancer Hospital
  • National Natural Science Foundation of China
  • Heilongjiang Provincial Postdoctoral Science Foundation
  • National Key Research and Development Program of China

Zitieren

APA

Liu, Y., Wang, Y., Guan, X., Wu, Q., Zhang, M., Cui, P., Wang, C., Chen, X., Meng, X., & Ma, T. (2023). Reversal of Cisplatin Resistance in Ovarian Cancer by the Multitargeted Nanodrug Delivery System Tf-Mn-MOF@Nira@CDDP. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.3c05374

Vancouver

Liu Y, Wang Y, Guan X, Wu Q, Zhang M, Cui P, et al. Reversal of Cisplatin Resistance in Ovarian Cancer by the Multitargeted Nanodrug Delivery System Tf-Mn-MOF@Nira@CDDP. ACS Applied Materials & Interfaces. 2023. doi:10.1021/acsami.3c05374

BibTeX
@article{Liu2023,
  author = {Liu, Yuan and Wang, Yiru and Guan, Xue and Wu, Qiong and Zhang, Mengjun and Cui, Ping and Wang, Can and Chen, Xiuwei and Meng, Xianwei and Ma, Tengchuang},
  title = {Reversal of Cisplatin Resistance in Ovarian Cancer by the Multitargeted Nanodrug Delivery System Tf-Mn-MOF@Nira@CDDP},
  journal = {ACS Applied Materials & Interfaces},
  year = {2023},
  doi = {10.1021/acsami.3c05374}
}
Kostenlos starten →